The South-East Asian Transgender Health Cohort
NCT05454579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2026-03-30
Summary
This is a prospective observational cohort study that will enroll 300 HIV-negative transgender people and 150 transgender people living with HIV from 4 community health centers in Thailand, Vietnam, and the Philippines. Each participant will be followed-up until the completion of 24 months.
Conditions
- HIV
- STIs
- HCV
Sponsors & Collaborators
-
amfAR, The Foundation for AIDS Research
collaborator OTHER -
Institute of HIV Research and Innovation Foundation, Thailand
lead OTHER
Principal Investigators
-
Nittaya Phanuphak, MD,PhD. · Institute of HIV Research and Innovation
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-02
- Primary Completion
- 2024-05-15
- Completion
- 2025-03-30
Countries
- Philippines
- Thailand
- Vietnam
Study Locations
More Related Trials
-
Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
NCT04050371 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men
NCT04593680 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community
NCT03120936 ·Status: COMPLETED ·Phase: PHASE4
-
The Women TDF-FTC Benchmark Study
NCT05057858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women
NCT03270969 ·Status: COMPLETED ·Phase: PHASE1
-
Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women
NCT03060785 ·Status: COMPLETED ·Phase: PHASE1
-
Same-Day Antiretroviral Therapy Initiation
NCT04032028 ·Status: ACTIVE_NOT_RECRUITING
-
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART
NCT05584397 ·Status: ENROLLING_BY_INVITATION
-
LA PrEP Impact and Cost-effectiveness (TEAMS)
NCT05774548 ·Status: RECRUITING ·Phase: NA
-
Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
NCT00517569 ·Status: UNKNOWN ·Phase: PHASE1
-
Anal HSIL Screening Algorithm
NCT05531799 ·Status: COMPLETED ·Phase: NA
-
A Long-term Follow-up of the HIV-NAT Cohort
NCT00411983 ·Status: RECRUITING
-
A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories
NCT05514509 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Transplantation and Raltegravir in HIV-Infected Patients
NCT01453192 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
NCT01546376 ·Status: UNKNOWN
-
Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
NCT00433030 ·Status: COMPLETED
-
Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR
NCT01286740 ·Status: COMPLETED ·Phase: PHASE2
-
The Compartmental Biology of HIV in the Male Genital Tract
NCT02638493 ·Status: COMPLETED
-
Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
NCT00532168 ·Status: COMPLETED ·Phase: PHASE4
-
Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens
NCT00627055 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Entry and Continuation in Care for People Living With HIV in French Guiana
NCT05354934 ·Status: UNKNOWN
-
A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection
NCT01296373 ·Status: COMPLETED
-
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF
NCT02121795 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
NCT00122512 ·Status: TERMINATED ·Phase: PHASE2
-
Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)
NCT04644029 ·Status: TERMINATED ·Phase: PHASE3